Remote monitoring for COPD flare-up prevention
Part of Lungs & breathing clinical trials.
This trial tests a remote monitoring system (BoraCare®) for people with COPD. It uses a wearable device and an early warning score to detect flare-ups early, so you can get faster care and avoid hospital stays.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have COPD confirmed by a lung specialist.
- You have been hospitalized for a COPD flare-up in the last 12 months.
- You speak French or have a caregiver who can help you use the monitoring device.
- You are enrolled in a French social security plan.
- You are not pregnant or nursing, and do not have serious unstable health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a wearable device that listens to your breathing at home. It may help detect early signs of a COPD flare-up so you can get care sooner. You can join if you have moderate to severe COPD and recently left the hospital for a flare-up.
This study tests a software program that uses machine learning to predict if you might have a COPD flare-up or get worse within 60 days after leaving the hospital. The goal is to help doctors provide better follow-up care and reduce emergency visits.
This study tests whether a wearable device and a smartphone app can predict when your COPD will flare up. It uses AI to spot early warning signs, so you might get help sooner.
This study tests a new approach to reduce flare-ups (sudden worsening of symptoms) in people with COPD. If you've had frequent flare-ups, this trial may help you manage your condition better.
This study tests whether a home high-flow nasal breathing device (myAirvo 3) helps people with COPD who recently needed hospital care for a flare-up. You would use the device at home and track symptoms, oxygen levels, and heart rate daily to see how well it works.
This study tests if monitoring your vital signs remotely (like oxygen levels and heart rate) can help improve care for people who need long-term oxygen therapy due to COPD or ILD. It may help you feel more supported at home.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.